Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Stock
Stocks
002399
CNE100000P02
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.36 CNY | +2.47% |
|
+10.57% | -12.13% |
| Market Cap | 13.76B 2.03B 1.78B 1.64B 1.51B 2.85B 196B 2.9B 19.58B 7.69B 95.58B 7.63B 7.46B 330B | P/E 2026 * |
17.9x | P/E 2027 * | 15.2x |
|---|---|---|---|---|---|
| Enterprise Value | 12.33B 1.82B 1.59B 1.47B 1.35B 2.56B 175B 2.6B 17.55B 6.89B 85.67B 6.84B 6.69B 296B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 2.3x |
| Free-Float |
14.33% | Yield 2026 * |
0.68% | Yield 2027 * | 0.77% |
| 1 day | +2.47% | ||
| 1 week | +10.57% | ||
| Current month | +15.37% | ||
| 1 month | +12.61% | ||
| 3 months | -9.44% | ||
| 6 months | -16.11% | ||
| Current year | -12.13% |
| 1 week | 9.22 |  | 10.41 |
| 1 month | 8.5 | | 10.41 |
| Current year | 8.5 | | 12.64 |
| 1 year | 8.5 | | 14.34 |
| 3 years | 6.89 | | 14.34 |
| 5 years | 6.89 | | 18.89 |
| 10 years | 6.89 | | 30.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Shan
CEO | Chief Executive Officer | 65 | 21/04/1998 |
Tan Li
PRN | Corporate Officer/Principal | 61 | 21/04/1998 |
Juan Chen
DFI | Director of Finance/CFO | 51 | 21/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tan Li
BRD | Director/Board Member | 61 | 21/04/1998 |
Li Li
CHM | Chairman | 62 | 21/04/1998 |
Yu Shan
BRD | Director/Board Member | 65 | 21/04/1998 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/5/23 | Sell | 11,200 | 0.0009% | |||
| 26/5/21 | Other | Chief Financial Officer | 459,588 | 0.2088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.47% | +10.57% | -14.45% | -11.68% | 1.98B | |
| +1.25% | -3.81% | +48.21% | +161.79% | 1,031B | |
| +0.46% | -3.82% | +51.23% | +56.65% | 595B | |
| +3.11% | +0.67% | +32.01% | +86.59% | 431B | |
| +0.42% | -1.16% | +29.43% | +23.64% | 326B | |
| +1.03% | -0.84% | +29.58% | +45.15% | 277B | |
| +0.49% | -5.44% | +21.00% | +23.80% | 263B | |
| +1.59% | +4.89% | -22.56% | -37.35% | 224B | |
| +2.82% | +1.41% | +23.31% | +61.84% | 193B | |
| +2.00% | -0.59% | +22.03% | +73.01% | 164B | |
| Average | +1.51% | -2.55% | +21.98% | +48.34% | 350.63B | |
| Weighted average by Cap. | +1.28% | -4.30% | +34.32% | +79.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.78B 853M 745M 689M 632M 1.2B 82.16B 1.22B 8.22B 3.23B 40.12B 3.2B 3.13B 139B | 6.27B 926M 810M 749M 687M 1.3B 89.26B 1.32B 8.93B 3.51B 43.59B 3.48B 3.4B 150B |
| Net income | 858M 127M 111M 102M 93.94M 178M 12.2B 181M 1.22B 480M 5.96B 476M 465M 20.57B | 999M 147M 129M 119M 109M 207M 14.21B 211M 1.42B 558M 6.94B 554M 542M 23.95B |
| Net Debt | -1.43B -211M -184M -170M -156M -296M -20.3B -301M -2.03B -798M -9.91B -791M -774M -34.22B | 668M 98.57M 86.16M 79.68M 73.12M 138M 9.5B 141M 950M 373M 4.64B 370M 362M 16.01B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | CNY 10.36 | +2.47% | 8,961,300 |
| 15/07/26 | CNY 10.11 | +2.54% | 9,568,360 |
| 14/07/26 | CNY 9.860 | +2.18% | 6,744,500 |
| 13/07/26 | CNY 9.650 | +1.15% | 6,637,420 |
| 10/07/26 | CNY 9.540 | +2.47% | 5,744,990 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 002399 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
